Drugs / MTX
last change Nov 2020 re-read 2 minutes ago

MTX

Developed for
rheumatoid arthritis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02647762 Comparator Oct 2017 → Nov 2020 rheumatoid arthritis Can-Fite BioPharma Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MTX ClinicalTrials.gov intervention name — accepted as the source's own label NCT02647762